Articles

Statistiques
  • 78 Articles

Owing to its multiple advantages, nanobodies have been widely applied and studied in the field of biological research. Beyond the mainstream research directions, they also hold great potential in the fields of food safety and agricultural development. Nowadays, this technology is gradually being applied to research in the field of transdermal…

Owing to its multiple advantages, nanobodies have been widely applied and studied in the field of biological research. Beyond the mainstream research directions, they also hold great potential in the fields of food safety and agricultural development. Nowadays, this technology is gradually being applied to research in the field of transdermal drug delivery.

  1.   19 Juillet 2024
  2.   Market Insights

Recently, Ivonescimab Injection, independently developed by Akeso-Sino Biopharmaceutical Co., Ltd. and the world's first of its kind, has been officially approved for marketing. Combined with chemotherapy, Ivonescimab Injection is expected to provide a brand-new and highly effective immunotherapeutic regimen for patients with locally advanced or…

Recently, Ivonescimab Injection, independently developed by Akeso-Sino Biopharmaceutical Co., Ltd. and the world's first of its kind, has been officially approved for marketing. Combined with chemotherapy, Ivonescimab Injection is expected to provide a brand-new and highly effective immunotherapeutic regimen for patients with locally advanced or metastatic non-squamous non-small cell lung cancer.

  1.   17 Juin 2024
  2.   Market Insights

Pathogenic microorganisms can cause a variety of infectious diseases. Large - scale outbreaks of infectious diseases such as Ebola hemorrhagic fever, COVID - 19 infection, and malaria pose severe threats to human life and health, and even trigger social crises. This has driven researchers to seek simpler and more effective methods for treating…

Pathogenic microorganisms can cause a variety of infectious diseases. Large - scale outbreaks of infectious diseases such as Ebola hemorrhagic fever, COVID - 19 infection, and malaria pose severe threats to human life and health, and even trigger social crises. This has driven researchers to seek simpler and more effective methods for treating infectious diseases. Controlling the source of infection, cutting off the route of transmission, and protecting susceptible populations are the keys to preventing and controlling infectious diseases.

  1.   28 Mai 2024
  2.   Market Insights

2024年5月25日,由武汉产业创新发展研究院(武创院)带领香港海外学人联合会的众多香港学者莅临武汉纳博生命科技有限公司(纳博生命)羊驼繁育实验基地进行访问考察。

  1.   27 Mai 2024
  2.   公司新闻

病原微生物可以引起各种各样的传染性疾病,埃博拉出血热、新冠病毒感染、疟疾等传染病疫情的大规模暴发,对人类生命健康造成严重威胁甚至引发社会危机,这促使研究人员寻求更加简洁有效的方法治疗传染病,而控制传染源,切断传播途径,保护易感人群是防控传染病的关键。

  1.   24 Mai 2024
  2.   市场见闻
Aucun article créé pour l'instant
Impossible de charger le contenu de l'info-bulle.
Support is Online
We're back! We are here to assist you. Please be patient, we will respond to your tickets shortly.
Official support hours
Monday To Friday
From 9:00AM To 6:00PM